The evolution of the martian core is widely assumed to mirror the characteristics observed for Earth's core. Data from experiments performed on iron-sulfur and iron-nickel-sulfur systems at pressures corresponding to the center of Mars indicate that its core is presently completely liquid and that it will not form an outwardly crystallizing iron-rich inner core, as does Earth. Instead, planetary cooling will lead to core crystallization following either a "snowing-core" model, whereby iron-rich solids nucleate in the outer portions of the core and sink toward the center, or a "sulfide inner-core" model, where an iron-sulfide phase crystallizes to form a solid inner core.
[1] Phosphorus is an important element believed to be present in the Earth's core. As a non-metal, its solubility in iron is limited, leading to the precipitation of phosphides at high concentrations. Here we present experimental results for the iron-rich portions of the Fe-P and Fe-P-S systems at 23 GPa. We find a Fe-P eutectic point occurring at 9 wt% P and 1275°C at 23 GPa. Up to 4 wt% P is soluble in the Fe-rich solid coexisting with the eutectic liquid at these conditions. The ternary Fe-P-S system displays a simple cotectic between the Fe-P and Fe-S binary eutectics with minimum melting temperature on the S-side at 1075°C. At subsolidus conditions there is complete solid solution between Fe 3 P and Fe 3 S. The high solubility of phosphorus in iron along with its miscibility in Fe 3 S and iron-sulfur liquids at high pressures, combined with expectation of only minor concentrations in planetary cores, indicate phosphorus will not form a distinct phase within terrestrial planet cores.
Objectives Schizophrenia is characterized by high levels of disability often resulting in increased healthcare utilization and spending. With expanding healthcare costs across all healthcare sectors, there is a need to understand how healthcare spending has changed over time. We conducted a population-based study using administrative health data from Alberta, Canada, to describe changes in medical complexity and direct healthcare spending among patients with schizophrenia over a 10-year period. Methods A serial cross-sectional study from January 1, 2008, to December 31, 2017, was conducted to determine changes in demographic characteristics, medical complexity, and costs among all adults (18 years or older) with schizophrenia. Total healthcare spending and sector-specific costs attributable to hospitalizations, emergency department visits, practitioner billings, and prescriptions were calculated and compared over time. Results Over the 10-year period the contact prevalence of patients with schizophrenia increased from 0.6% ( n = 16,183) to 1.0% ( n = 33,176) within the province. There was a marked change in medical complexity with the number of patients living with 3 or more comorbidities increasing from 33.0% to 47.3%. Direct annual healthcare costs increased 2-fold from 321 to 639 million CAD (493 million USD) with a 7-fold increase in medication expenditures over the 10-year time frame. As of 2017, spending on pharmaceutical treatment surpassed hospitalizations as the leading spending category in this population. Conclusions Healthcare spending among patients with schizophrenia continues to increase and may be partially attributable to growing rates of multimorbidity within this population. Although promising second-generation antipsychotic medications have entered the market, this has resulted in considerable changes in the distribution of healthcare spending over time. These findings will inform policy discussions around resource allocation and efforts to curb health spending while also improving care for patients with schizophrenia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.